422 related articles for article (PubMed ID: 16054054)
1. A potential link between muscle peroxisome proliferator- activated receptor-alpha signaling and obesity-related diabetes.
Finck BN; Bernal-Mizrachi C; Han DH; Coleman T; Sambandam N; LaRiviere LL; Holloszy JO; Semenkovich CF; Kelly DP
Cell Metab; 2005 Feb; 1(2):133-44. PubMed ID: 16054054
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of insulin signaling through inhibition of tissue lipid accumulation by activation of peroxisome proliferator-activated receptor (PPAR) alpha in obese mice.
Ide T; Tsunoda M; Mochizuki T; Murakami K
Med Sci Monit; 2004 Oct; 10(10):BR388-95. PubMed ID: 15448592
[TBL] [Abstract][Full Text] [Related]
3. Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents.
Turner N; Bruce CR; Beale SM; Hoehn KL; So T; Rolph MS; Cooney GJ
Diabetes; 2007 Aug; 56(8):2085-92. PubMed ID: 17519422
[TBL] [Abstract][Full Text] [Related]
4. Leptin stimulates fatty acid oxidation and peroxisome proliferator-activated receptor alpha gene expression in mouse C2C12 myoblasts by changing the subcellular localization of the alpha2 form of AMP-activated protein kinase.
Suzuki A; Okamoto S; Lee S; Saito K; Shiuchi T; Minokoshi Y
Mol Cell Biol; 2007 Jun; 27(12):4317-27. PubMed ID: 17420279
[TBL] [Abstract][Full Text] [Related]
5. Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha.
Yoon MJ; Lee GY; Chung JJ; Ahn YH; Hong SH; Kim JB
Diabetes; 2006 Sep; 55(9):2562-70. PubMed ID: 16936205
[TBL] [Abstract][Full Text] [Related]
6. Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice.
Verreth W; De Keyzer D; Pelat M; Verhamme P; Ganame J; Bielicki JK; Mertens A; Quarck R; Benhabilès N; Marguerie G; Mackness B; Mackness M; Ninio E; Herregods MC; Balligand JL; Holvoet P
Circulation; 2004 Nov; 110(20):3259-69. PubMed ID: 15533870
[TBL] [Abstract][Full Text] [Related]
7. Improvement of dyslipidemia, insulin sensitivity, and energy balance by a peroxisome proliferator-activated receptor alpha agonist.
Chen X; Matthews J; Zhou L; Pelton P; Liang Y; Xu J; Yang M; Cryan E; Rybczynski P; Demarest K
Metabolism; 2008 Nov; 57(11):1516-25. PubMed ID: 18940388
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of peroxisomal proliferator activated receptors alpha and delta in skeletal muscle in response to changes in diet and exercise.
Kannisto K; Chibalin A; Glinghammar B; Zierath JR; Hamsten A; Ehrenborg E
Int J Mol Med; 2006 Jan; 17(1):45-52. PubMed ID: 16328010
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of pyruvate dehydrogenase kinase isoform 4 (PDK4) protein expression in oxidative skeletal muscle does not require the obligatory participation of peroxisome-proliferator-activated receptor alpha (PPARalpha).
Holness MJ; Bulmer K; Gibbons GF; Sugden MC
Biochem J; 2002 Sep; 366(Pt 3):839-46. PubMed ID: 12099888
[TBL] [Abstract][Full Text] [Related]
10. A nonthiazolidinedione peroxisome proliferator-activated receptor α/γ dual agonist CG301360 alleviates insulin resistance and lipid dysregulation in db/db mice.
Jeong HW; Lee JW; Kim WS; Choe SS; Shin HJ; Lee GY; Shin D; Lee JH; Choi EB; Lee HK; Yon GH; Cho B; Kim HR; Choi SH; Chung YS; Park SB; Chung H; Ro S; Kim JB
Mol Pharmacol; 2010 Nov; 78(5):877-85. PubMed ID: 20724462
[TBL] [Abstract][Full Text] [Related]
11. A novel PPARalpha agonist ameliorates insulin resistance in dogs fed a high-fat diet.
Tsunoda M; Kobayashi N; Ide T; Utsumi M; Nagasawa M; Murakami K
Am J Physiol Endocrinol Metab; 2008 May; 294(5):E833-40. PubMed ID: 18212024
[TBL] [Abstract][Full Text] [Related]
12. Reduced expression of nuclear-encoded genes involved in mitochondrial oxidative metabolism in skeletal muscle of insulin-resistant women with polycystic ovary syndrome.
Skov V; Glintborg D; Knudsen S; Jensen T; Kruse TA; Tan Q; Brusgaard K; Beck-Nielsen H; Højlund K
Diabetes; 2007 Sep; 56(9):2349-55. PubMed ID: 17563058
[TBL] [Abstract][Full Text] [Related]
13. Effect of GCP-02, a PPARalpha/gamma dual activator, on glucose and lipid metabolism in insulin-resistant mice.
Wang ZJ; Liu Q; Li PP; Zou CH; Shen ZF
Eur J Pharmacol; 2008 Feb; 580(1-2):277-83. PubMed ID: 18048028
[TBL] [Abstract][Full Text] [Related]
14. A type IV P-type ATPase affects insulin-mediated glucose uptake in adipose tissue and skeletal muscle in mice.
Dhar MS; Yuan JS; Elliott SB; Sommardahl C
J Nutr Biochem; 2006 Dec; 17(12):811-20. PubMed ID: 16517145
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor alpha deficiency modifies glucose handling by isolated mouse adipocytes.
Walker CG; Sugden MC; Gibbons GF; Holness MJ
J Endocrinol; 2007 Apr; 193(1):39-43. PubMed ID: 17400801
[TBL] [Abstract][Full Text] [Related]
16. Metabolic effects of insulin on cardiomyocytes from control and diabetic db/db mouse hearts.
Carroll R; Carley AN; Dyck JR; Severson DL
Am J Physiol Endocrinol Metab; 2005 May; 288(5):E900-6. PubMed ID: 15632103
[TBL] [Abstract][Full Text] [Related]
17. 18F9 (4-(3,6-bis (ethoxycarbonyl)-4,5,6,7-tetrahydrothieno (2,3-c) pyridin-2-ylamino)-4-oxobutanoic acid) enhances insulin-mediated glucose uptake in vitro and exhibits antidiabetic activity in vivo in db/db mice.
Anandharajan R; Sayyed SG; Doshi LS; Dixit P; Chandak PG; Dixit AV; Brahma MK; Deshmukh NJ; Gupte R; Damre A; Suthar J; Padigaru M; Sharma SD; Nemmani KV
Metabolism; 2009 Oct; 58(10):1503-16. PubMed ID: 19608207
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor-alpha deficiency protects aged mice from insulin resistance induced by high-fat diet.
Cha DR; Han JY; Su DM; Zhang Y; Fan X; Breyer MD; Guan Y
Am J Nephrol; 2007; 27(5):479-82. PubMed ID: 17652964
[TBL] [Abstract][Full Text] [Related]
19. PAR-5359, a well-balanced PPARalpha/gamma dual agonist, exhibits equivalent antidiabetic and hypolipidemic activities in vitro and in vivo.
Kim MK; Chae YN; Son MH; Kim SH; Kim JK; Moon HS; Park CS; Bae MH; Kim E; Han T; Choi HH; Shin YA; Ahn BN; Lee CH; Lim JI; Shin CY
Eur J Pharmacol; 2008 Oct; 595(1-3):119-25. PubMed ID: 18727927
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the actions of peroxisome proliferator-activated receptor alpha on obesity by estrogen.
Jeong S; Yoon M
Obesity (Silver Spring); 2007 Jun; 15(6):1430-40. PubMed ID: 17557980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
